S&P 500 7,623.68 −0.52%
Nasdaq 25,955.34 −0.21%
S&P/TSX 35,788.18 −0.52%
Apple 347.73 −0.14%
Nvidia 210.96 −0.59%
Microsoft 524.51 +0.66%
Shopify 236.24 −0.07%
Royal Bank 281.77 −0.36%
CAD/USD 0.7141 −0.01%
CLOSED · 06:35 ET
Market ClerkRecap
Sat Oct 24 · markets closed6 signals on Oct 2394 insider buys this week · $48.3MCIRO short report next: Oct 31The week ahead

BIOA

BioAge Labs, Inc.
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
5.10
−0.43 −7.78%
USD · close Oct 23

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $234.1MP/E —DIV YIELD —FCF YIELD -37.63%REV TTM $10.4M +168.1%NET INCOME −$94.5MNET CASH $66.9M52W 4.84 – 25.10SEC XBRL · TTM TO Invalid Date

How BIOA rewrote its risk factors

10-K ITEM 1A · YEAR OVER YEAR
We have one 10-K for BIOA (FY2024, 25,780 words of risk factors). The comparison appears when the next annual report lands. Read it on EDGAR ↗
Watch BIOA. Know when insiders buy.
One email the day a filing lands. Free.